Cystathionine gamma-lyase of perivascular adipose tissue with reversed regulatory effect in diabetic rat artery

References

• Miao CY, Li ZY. The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol. 2012;165(3):643–658.
   Web of Science ®Google Scholar
• Takaoka M, Suzuki H, Shioda S, Sekikawa K, Saito Y, Nagai R, Masataka S. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler Thromb Vasc Biol. 2010;30(8):1576–1578.
   PubMed Web of Science ®Google Scholar
• Cinti S. Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J Endocrinological Investig. 2002;25(10):823–835.
   PubMed Web of Science ®Google Scholar
• Gollasch M, Dubrovska G. Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol Sci. 2004;25(12):647–653.
   PubMed Web of Science ®Google Scholar
• Zavaritskaya O, Zhuravleva N, Schleifenbaum J, Gloe T, Devermann L, Kluge R, Mladenov M, Frey M, Gagov H, Fésüs G, Gollasch M, Schubert R. Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction. Hypertension. 2013;61(1):151–159.
   PubMed Web of Science ®Google Scholar
• Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM, Lee RM. Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res. 2006;71(2):363–373.
   PubMed Web of Science ®Google Scholar
• Gao YJ, Zeng ZH, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, Lamy A, Semelhago L, Lee RM. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg. 2005;130(4):1130–1136.
   PubMed Web of Science ®Google Scholar
• Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002;16:1057–1063.
   PubMed Web of Science ®Google Scholar
• Thalmann S, Meier CA. Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res. 2007;75(4):690–701.
   PubMed Web of Science ®Google Scholar
• Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, Rudich S, Weintraub NL. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res. 2009;104(4):541–549.
   PubMed Web of Science ®Google Scholar
• Guzik T, Mangalat D, Korbut R. Adipocytokines – novel link between inflammation and vascular function? J Physiol Pharmacol. 2007;54:505–528.
   Google Scholar
• Eringa EC, Bakker W, van Hinsbergh VWM. Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vasc Pharmacol. 2012;56:204–209.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome. Circulation. 2009;120(16):1640–1645.
   PubMed Web of Science ®Google Scholar
• Lu C, Su LY, Lee RM, Gao YJ. Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur J Pharmacol. 2010;634(1–3):107–112.
   PubMed Web of Science ®Google Scholar
• Gálvez-Prieto B, Somoza B, Gil-Ortega M, García-Prieto CF, de Las Heras AI, González MC, Arribas S, Aranguez I, Bolbrinker J, Kreutz R, Ruiz-Gayo M, Fernández-Alfonso MS. Anticontractile effect of perivascular adipose tissue and leptin are reduced in hypertension. Front Pharmacol. 2012;3:103.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, Gollasch M. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension. 2004;44:271–276.
   PubMed Web of Science ®Google Scholar
• Fang L, Zhao J, Chen Y, Ma T, Xu G, Tang C, Liu X, Geng B. Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J Hypertens. 2009;27(11):2174–2185.
   PubMed Web of Science ®Google Scholar
• Li L, Hsu A, Moore PK. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and inflammation – a tale of three gases. Pharm Ther. 2009;123:386–400.
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 2001;20(21):6008–6016.
   PubMed Web of Science ®Google Scholar
• Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids. 2011;41(1):113–121.
   PubMed Web of Science ®Google Scholar
• Köhn C, Schleifenbaum J, Szijártó IA, Markó L, Dubrovska G, Huang Y, Gollasch M. Differential effects of cystathionine-γ-lyase-dependent vasodilatory H2S in periadventitial vasoregulation of rat and mouse aortas. PLoS ONE 2012;7(8): e41951.
   PubMed Web of Science ®Google Scholar
• Schleifenbaum J, Köhn C, Voblova N, Dubrovska G, Zavarirskaya O, Gloe T, Crean CS, Luft FC, Huang Y, Schubert R, Gollasch M. Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide. J Hypertens. 2010;28(9):1875–1882.
   PubMed Web of Science ®Google Scholar
• Soldovieri MV, Miceli F, Taglialatela M. Driving with no brakes: molecular pathophysiology of Kv7 potassium channels. Physiology. 2011;26(5):365–376.
   PubMed Web of Science ®Google Scholar
• Yang G, Wu L, Bryan S, Khaper N, Mani S, Wang R. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc Res. 2010;86:487–495.
   PubMed Web of Science ®Google Scholar
• Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008;322:587–590.
   PubMed Web of Science ®Google Scholar
• Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007;6:917–935.
   PubMed Web of Science ®Google Scholar
• Wagner CA. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator. J Nephrol. 2009;22(2):173–176.
   PubMed Web of Science ®Google Scholar
• Sivarajah A, McDonald MC, Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock. 2006;26(2):154–161.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Caliendo G, Santagada V, Cirino G. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br J Pharmacol. 2010;159(6):1236–1246.
   PubMed Web of Science ®Google Scholar
• Asdaq SM, Inamdar MN. Potential of garlic and its active constituent, S-allyl cysteine, as a antihypertensive and cardioprotective in presence of captopril. Phytomedicine. 2010;17:1016–1026.
   PubMed Web of Science ®Google Scholar
• Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutr J. 2002;1:4.
   PubMed Web of Science ®Google Scholar
• Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, Darley-Usmar VM, Doeller JE, Kraus DW. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA. 2007;104(46):17977–17982.
   PubMed Web of Science ®Google Scholar
• Wojcicka G, Jamroz-Wisniewska A, Atanasova P, Chaldakov GN, Chylińska-Kula B, Bełtowski J. Differential effects of statins on endogenous H2S formation in perivascular adipose tissue. Pharmacol Res. 2011;63:68–76.
   PubMed Web of Science ®Google Scholar
• Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, Tooke JE, Shore AC. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia. 2010;53(8):1722–1726.
   PubMed Web of Science ®Google Scholar
• Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, Bocchini JA. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal. 2010;12(11):1333–1337.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gerö D, Szoleczky P, Chang T, Zhou Z, Wu L, Wang R, Papapetropoulos A, Szabo C. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci USA. 2011;108(33):13829–13834.
   PubMed Web of Science ®Google Scholar